we have to introduce our ceo, mark bertolini, and george barrett, and knox singleton.he money we wasted, and one of the most exciting, you know, we see the genome, and i was hoping we'd get more therapeutics by now. it takes a long time to go, obviously, from a lab bench into a patient setting, but one thing we should be able to do is do a lot more in preventative medicine if you can find things that predispose someone to a chronic illness. i don't know how much progress we're making or how much illness is not environmental, not all based on the genome, but the part that is, we should be able to save a lot of money by preventing people from getting sick in the first place. >> well, i don't know about 75, but my prediction is that we're going to be hurdling towards 100 and the number of people over 65, the traditional definition of seniorhood is going to go dramatically. it's going to be partly driven by the genomic revolution because your ability to predict is the ability to prevent whether it's diabetes, whether it's stroke, heart disease, cancer. today, it's a new fi